Milestone Scientific Announces Initial Shipments of Single Tooth Anesthesia (STA(TM)) Delivery System
Purchase Orders Received From Henry Schein, Inc. Now Being Fulfilled
LIVINGSTON, N.J., March 14 /PRNewswire-FirstCall/ -- Milestone Scientific, Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies used by medical and dental professionals worldwide, today announced that it has commenced shipments of its newest product offering, the Single Tooth Anesthesia (STA(TM)) Delivery System in partial fulfillment of previously announced purchase orders received from Henry Schein, Inc., the Company's exclusive distributor in the U.S. and Canada.
According to Leonard Osser, Chairman and CEO of Milestone Scientific, "These initial shipments of the STA Delivery System to Henry Schein's customers represent a significant step forward in obtaining fast market adoption of this innovative and technologically advanced system by dental professionals. We expect that early adopters of the STA System will prove to be invaluable sources of insight and information regarding the powerful functionality and user benefits of the system, helping to build a meaningful library of product testimonials and a solid base of professional references that will support and promote Henry Schein's sales and marketing efforts. The present controlled soft introduction of our STA Delivery System is designed to develop grass-roots support in the field prior to our full scale launch of the STA System later this year."
About Milestone Scientific, Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system, which uses this technology, provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2006. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief Strategist 407-585-1080 or via email at email@example.com SOURCE Milestone Scientific, Inc.
Released March 14, 2007